| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
An evaluation of the potential cost reductions resulting from the use of clodronate in the treatment of metastatic carcinoma of the breast to bone
|
Biermann, W.A.
|
|
1991
|
12 |
S1 |
p. S37-S42
6 p.
|
article
|
| 2 |
Clinical consequences of osteolytic bone metastases
|
Namer, M.
|
|
1991
|
12 |
S1 |
p. S7-
1 p.
|
article
|
| 3 |
Clodronate: The potential for the future
|
Powles, T.
|
|
1991
|
12 |
S1 |
p. S43-S44
2 p.
|
article
|
| 4 |
Editorial Board
|
|
|
1991
|
12 |
S1 |
p. IFC-
1 p.
|
article
|
| 5 |
Incidence, prevalence and distribution of bone metastases
|
Tubiana-Hulin, M.
|
|
1991
|
12 |
S1 |
p. S9-S10
2 p.
|
article
|
| 6 |
Management of breast cancer with bone metastases
|
Clavel, M.
|
|
1991
|
12 |
S1 |
p. S11-S12
2 p.
|
article
|
| 7 |
Mechanisms of osteolytic bone destruction
|
Mundy, G.R.
|
|
1991
|
12 |
S1 |
p. S1-S6
6 p.
|
article
|
| 8 |
New French studies of clodronate in cancer-induced osteolysis
|
Burki, F.
|
|
1991
|
12 |
S1 |
p. S35-
1 p.
|
article
|
| 9 |
Rationale for the use of bisphosphonates in bone metastases
|
Kanis, J.A.
|
|
1991
|
12 |
S1 |
p. S13-S18
6 p.
|
article
|
| 10 |
The use of clodronate in multiple myeloma
|
Delmas, P.D.
|
|
1991
|
12 |
S1 |
p. S31-S34
4 p.
|
article
|
| 11 |
Treatment of hypercalcaemia of malignancy with clodronate
|
Bonjour, J-P.
|
|
1991
|
12 |
S1 |
p. S19-S23
5 p.
|
article
|
| 12 |
Treatment of skeletal disease in breast cancer with clodronate
|
Paterson, A.H.G.
|
|
1991
|
12 |
S1 |
p. S25-S30
6 p.
|
article
|
Journal description